Biocon drops after USFDA delays decision on biosimilar – Business Standard


Biocon drops after USFDA delays decision on biosimilar
Business Standard
Biocon announced after market hours yesterday, 30 August 2017, that the US Food and Drug Administration (USFDA) has delayed by three months its decision on whether it will approve Biocon and Mylan's breast cancer biosimilar drug while it reviews ...

Biocon drops after USFDA delays decision on biosimilar – Business Standard Kitimi Business.

Zydus Cadila gets USFDA nod for Hepatitis B drug – Ultra News


Ultra News

Zydus Cadila gets USFDA nod for Hepatitis B drug
Ultra News
Mylan and Biocon submits breast cancer drug application to USFDA Mylan N.V. and Biocon Ltd. said they submitted Mylan's biologics license application for a proposed biosimilar Trastuzumab, to the U.S. Food and Drug Administration.Biosimilar trastuzumab ...

and more »

Zydus Cadila gets USFDA nod for Hepatitis B drug – Ultra News Kitimi Business.

Zydus Cadila gets USFDA nod for Hepatitis B drug – Ultra News


Ultra News

Zydus Cadila gets USFDA nod for Hepatitis B drug
Ultra News
Mylan and Biocon submits breast cancer drug application to USFDA Mylan N.V. and Biocon Ltd. said they submitted Mylan's biologics license application for a proposed biosimilar Trastuzumab, to the U.S. Food and Drug Administration.Biosimilar trastuzumab ...

and more »

Zydus Cadila gets USFDA nod for Hepatitis B drug – Ultra News Kitimi Business.

Dr Reddy’s launches anti-fungal ointment in the US – Hindu Business Line


Dr Reddy's launches anti-fungal ointment in the US
Hindu Business Line
Pharma major Dr Reddy's Laboratories Ltd has launched Nystatin and Triamcinolone Acetonide Cream in the United States market. This was approved by the US Food & Drug Administration (USFDA), the Hyderabad-based company said in a release on ...

and more »

Dr Reddy’s launches anti-fungal ointment in the US – Hindu Business Line Kitimi Health.

Strides Shasun R&D unit gets USFDA inspection closure report – Moneycontrol.com


Moneycontrol.com

Strides Shasun R&D unit gets USFDA inspection closure report
Moneycontrol.com
"The company's Control Test Laboratory, which is part of its R&D centre in Chennai was inspected by the USFDA in August 2016 has received the Establishment Inspection Report (EIR), thereby confirming the closure of the inspection. The laboratory ...

and more »

Strides Shasun R&D unit gets USFDA inspection closure report – Moneycontrol.com Kitimi Health.

Strides Shasun gains on receiving EIR for R&D Centre in Chennai – Mint Market Info


Strides Shasun gains on receiving EIR for R&D Centre in Chennai
Mint Market Info
Strides Shasun's control test laboratory, which is part of its R&D Centre in Chennai was inspected by the U.S. Food and Drug Administration (USFDA) in August 2016 has received the Establishment Inspection Report (EIR), thereby confirming the closure of ...

and more »

Strides Shasun gains on receiving EIR for R&D Centre in Chennai – Mint Market Info Kitimi Health.

Alembic Pharma gets US FDA nod for anti-migraine drug – Economic Times


Economic Times

Alembic Pharma gets US FDA nod for anti-migraine drug
Economic Times
"The company has received approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Zolmitriptan Orally Disintegrating Tablets, 2.5 and 5 mg," Alembic Pharmaceuticals said in a BSE filing.

and more »

Alembic Pharma gets US FDA nod for anti-migraine drug – Economic Times Kitimi Health.

Sun Pharma Unveils First Branded Ophthalmic Product In U.S. – BloombergQuint


BloombergQuint

Sun Pharma Unveils First Branded Ophthalmic Product In U.S.
BloombergQuint
Approved by the U.S. Food and Drug Administration (USFDA) on April 8, 2016, BromSite (bromfenac ophthalmic solution) 0.075 percent is the first NSAID approved to prevent ocular pain and treat inflammation in the eye following cataract surgery ...

and more »

Sun Pharma Unveils First Branded Ophthalmic Product In U.S. – BloombergQuint Kitimi Health.

Topography Guided Lasik promises revolution for spectacles Wearers – The Hans India


The Hans India

Topography Guided Lasik promises revolution for spectacles Wearers
The Hans India
The symposium discussed the revolutionary technologies of Topography guided lasik procedure, the first technology approved by USFDA and its benefits to the patients with refractive problems.Dr.Rohit Shetty – Vice Chairman of Narayana Netralaya said ...

Topography Guided Lasik promises revolution for spectacles Wearers – The Hans India Kitimi Health.

Pharmaceuticals Newsletter – November 21 to 25, 2016 – Indiainfoline


Pharmaceuticals Newsletter - November 21 to 25, 2016
Indiainfoline
This week, Natco Pharma gets USFDA approval for generic Budesonide Capsules for USA market, Suven Life Sciences Q2 FY17 PAT at Rs 26.5 crore. IIFL presents a weekly snapshot of all the major happenings in the pharmaceuticals industry, nationally ...

and more »

Pharmaceuticals Newsletter – November 21 to 25, 2016 – Indiainfoline Kitimi Health.